GPCR Podcast << Back to podcast list Murat Tunaboylu & Ben Holland About Murat Tunaboylu "Murat Tunaboylu GPCR About Ben Holland "Ben gained his masters in Engineering Science from Oxford, taking a specialisation nearly 10 years, applying it to antibody generation, analysis, and property prediction since 2017" Ben

Benjamin Myers Ben Myers is an assistant professor at the University of Utah School of Medicine in Salt Ben’s research focuses on Smoothened and other class F GPCRs which play essential roles in embryonic More recently, Ben’s lab has begun studying GPCR signaling pathways that operate within the primary cilium Ben studied developmental and cancer signaling as a postdoctoral fellow with Philip Beachy at Stanford Prior to that, Ben received his Ph.D. from UCSF in 2008, where he worked with David Julius on the structure

Aina Oliver-Cáldes, Kristin Rathje, James A Davis, David Fandrei, Vladan Vucinic, Soraya Kharboutli, Ben-Niklas

Oncology and Immunology Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone Published date May 1, 2024 Abstract "G protein-coupled Fibrous dysplasia (FD) of the bone is characterized by fibrotic, expansile bone lesions caused by activating Bone fibrosis remained evident after treatment. Notably, LGK974 caused significant bone loss in control mice.

Because the TA-mediated mechanism is a “one and done” mechanism that is irreversible and prevents the Jose Rizo-Rey as a graduate student to elucidate the mechanisms of neurotransmitter release. Jones (Harvard Medical School); Jeffrey S.

’s research interests lies in the elucidation of signal transduction pathways in cancer, immune and bone The Rottapel lab has shown that 3BP2 has pleiotrophic function controlling bone homeostasis, immune cell

She has done extensive work on the molecular pharmacology of opioid receptors and is currently focusing

Bone marrow (BM) samples were collected at baseline for genomic and transcriptomic analysis (n = 32). remission, with or without hematologic count recovery (CR/CRi), and 32% exhibited a ≥50% reduction in bone

Graciela has done extensive work on the molecular pharmacology of opioid receptors, exploring their signaling

physiology, receptor molecular pharmacology in cells, and animal models, and as he puts it has now he’s "gone

Cone’s lab was a clear choice for a postdoc. Dr. Cone was the first to clone the melanocortin receptors (the GPCRs that led to the discovery of MRAP2)

parathyroid glands of patients with hyperparathyroidism and their impact on body calcium homeostasis and bone

allows predictions of drug activity in all physiological systems, not only the system where testing is done

Zhao , Vincent DiGiacomo , Mariola Ferreras-Gutierrez , Shiva Dastjerdi , Alain Ibáñez de Opakua , Jong-Chan

We detected BLT2 expression in bone marrow derived and peritoneal macrophages of mouse models.

cell motility. " Authors Yu Jin Lee , Kyeong Jin Shin , Hyun-Jun Jang , Jin-Sun Ryu , Chae Young Lee , Jong

Authors Claes Dahlgren, Huamei Forsman, Martina Sundqvist, Lena Björkman, Jonas Mårtensson Tags GPCR

almost no abnormalities in myeloid cell differentiation and compartmentalization in the spleen and bone

Her current research focuses on how metabolic GPCRs cross-talk and interact to regulate appetite and bone

awarded the Young Investigator Transdisciplinary Research Award (2022-2023 and 2023-2024) from the bone

Authors Jong Min Hong , Jin-Woo Lee , Dong-Seung Seen , Jae-Yeon Jeong , Won-Ki Huh Tags Cancer , Chemokine

Get your All-Access ticket before they're gone by visiting Eventbrite today!

They also highlighted the need for a work-life balance and the joy of a well-done job.